Monday, 28 September 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Financial Results · Q4 FY26

Swasti Vinayaka Synthetics Q4 FY26 Results: Net Profit ₹1.2 Cr, Up 140.0% YoY

Swasti Vinayaka Synthetics Ltd reported revenue from operations of ₹6.9 Cr (-34.9% YoY) and net profit of ₹1.2 Cr (+140.0% YoY) for Q4 FY26.

Q4 FY26 at a glance · ₹ crore
MetricQ4 FY26Q3 FY26Q4 FY25
Revenue from operations6.99.810.6
Other income0.20.00.1
Total income7.19.910.7
Profit before exceptional items & tax2.21.21.3
Profit before tax2.21.21.3
Net profit1.21.20.5
Operating margin31.0%12.1%12.1%

A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.

Growth
Net profit, year on year+140.00%
Net profit, quarter on quarter+0.00%
Revenue, year on year-34.90%
Source

BSE results filing, NSE: SWASTIVI. Figures extracted from the filing.

Read the filing ↗

Swasti Vinayaka Synthetics Ltd: key numbers

Share price
₹3.74
Market cap
₹33.66 Cr
Revenue (annual)
₹32.03 Cr
Net profit (annual)
₹3.05 Cr
P/E (TTM)
10.1×Sector 55.7×
Promoter holding
51.00%+0.00% QoQ
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Swasti Vinayaka Synthetics Ltd

All →
18:05 IST BSE
Other Announcement

Swasti Vinayaka Synthetics Other Announcement

Swasti Vinayaka Synthetics informed shareholders of the web-link for accessing the FY 2025-26 Annual Report, as per Regulation 36(1)(b).

17:59 IST BSE
Annual Report

Swasti Vinayaka Synthetics Annual Report

Swasti Vinayaka Synthetics Ltd has submitted its Annual Report for the financial year ended March 31, 2026, as required under SEBI LODR regulations.

17:50 IST BSE
Annual General Meeting

Swasti Vinayaka Synthetics Annual General Meeting

Swasti Vinayaka Synthetics Limited has issued the notice for its 44th Annual General Meeting scheduled for September 29, 2026, to address financial statements and director appointments.